Rheumatoid Arthritis Adult Stem Cell Protocol, Medistem (PINKSHEETS: MEDS)
Peer reviewed paper details rationale and implementation of new arthritis therapy titled, “Autologous stromal vascular fraction cells: A tool for facilitating tolerance in rheumatic disease,” describes the 1st use of a patient’s own fat stem cells for treatment of rheumatoid arthritis.
Referencing a case (report) of a 67-year-old American woman who recovered from rheumatoid arthritis after intravenous treatment with adult stem cells. Medistem previously identified and filed intellectual property covering the co-purification of high concentrations of T regulatory cells using protocols that enrich for adipose derived stem cells, a finding that was later published by Diane Mathis’s group from Harvard University.
”We are very excited that Medistem’s protocol for isolation of a patient’s own fat derived stem cells and T regulatory cells, which produced promising results in multiple sclerosis, appears to be useful in rheumatoid arthritis, another autoimmune disease,” said Neil Riordan, Chairman of Medistem.
